| Literature DB >> 32210080 |
Hui Gao1, Kan Wang2,3, William W Au4,5, Wensui Zhao1, Zhao-Lin Xia2.
Abstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally and ozone exposure is a main cause of its disease burden. However, studies on COPD hospitalizations from short-term ambient level ozone exposure have not generated consensus results. To address the knowledge gap, comprehensive and systematic searches in several databases were conducted using specific keywords for publications up to February 14, 2020. Random-effect models were used to derive overall excess risk estimates between short-term ambient-level ozone exposure and COPD hospitalizations. The influence analyses were used to test the robustness of the results. Both meta-regression and subgroup analyses were used to explore the sources of heterogeneity and potential modifying factors. Based on the results from 26 eligible studies, the random-effect model analyses show that a 10 µg/m3 increase in maximum 8-h ozone concentration was associated with 0.84% (95% CI: 0.09%, 1.59%) higher COPD hospitalizations. The estimates were higher for warm season and multiple-day lag but lower for old populations. Results from subgroup analyses also indicate a multiple-day lag trend and bigger significant health effects during longer day intervals. Although characteristics of individual studies added modest heterogeneity to the overall estimates, the results remained robust during further analyses and exhibited no evidence of publication bias. Our systematic review and meta-analysis indicate that short-term ambient level ozone exposure was associated with increased risk of COPD hospitalizations. The significant association with multiple-day lag trend indicates that a multiple-day exposure metric should be considered for establishing ambient ozone quality and exposure standards for improvement of population health. Future investigations and meta-analysis studies should include clinical studies as well as more careful lag selection protocol.Entities:
Keywords: chronic obstructive pulmonary disease; environmental health; meta-analysis; ozone
Year: 2020 PMID: 32210080 PMCID: PMC7143242 DOI: 10.3390/ijerph17062130
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Study selection flowchart (searching before September 19, 2019).
Contextual details of studies included in the meta-analysis.
| Author | Location | Published | Period | Study Design | Data Source | Population | Definition of Outcome | Influenza |
|---|---|---|---|---|---|---|---|---|
| Malig et al. | USA | 2016 | 2005–2008 | Case crossover | EDVs | All | ICD-9 | Adjust |
| Pothirat et al. | Thailand | 2019 | 2016–2017 | Time series | EDVs & HAs | All | ICD-10 | No |
| Szyszkowicz et al. | Canada | 2018 | 2004–2011 | Case crossover | EDVs | ≥55 years | ICD-10 | Adjust |
| Lee et al. | China | 2007 | 1996–2003 | Case crossover | HAs | All | ICD-9 | No |
| Fusco et al. | Italy | 2001 | 1995–1997 | Time series | HAs | All | ICD-9 | Adjust |
| Schwartz et al. | USA | 1994 | 1986–1989 | Time series | HAs | ≥65 years | ICD-9 | No |
| Morgan et al. | Australia | 1998 | 1990–1994 | Time series | HAs | ≥65 years | ICD-9 | No |
| Tenias et al. | Spain | 2002 | 1994–1995 | Time series | EDVs | ≥14 years | ICD-9 | No |
| Peel et al. | USA | 2005 | 1993–2000 | Time series | EDVs | All | ICD-9 | Adjust |
| Liang et al. | China | 2019 | 2013–2017 | Time series | HAs | ≥18 years | ICD-10 | No |
| Reid et al. | USA | 2019 | 2008 | Time series | EDVs & HAs | All | ICD-9 | No |
| Yang et al. | Canada | 2005 | 1994–1998 | Time series | EDVs | ≥65 years | ICD-9 | No |
| Halonen et al. | Finland | 2010 | 1998–2004 | Time series | EDVs & HAs | ≥65 years | ICD-10 | Adjust |
| Anderson et al. | UK | 2001 | 1994–1996 | Time series | HAs | ≥65 years | ICD-9 | Adjust |
| Qiu et al. | China | 2013 | 1998–2007 | Time series | EDVs | All | ICD-9 | Adjust |
| Dab et al. | France | 1996 | 1987–1992 | Time series | HAs | All | ICD-9 | Adjust |
| Ko et al. | China | 2007 | 2000–2004 | Time series | EDVs | All | ICD-9 | No |
| Hinwood et al. | Australia | 2006 | 1992–1998 | Case crossover | HAs | All | ICD-9 | No |
| Arbex et al. | Brazil | 2009 | 2001–2003 | Time series | EDVs | ≥40 years | ICD-10 | No |
| Ding et al. | China | 2017 | 2000–2013 | Case crossover | EDVs | 65–79 years | ICD-9 | No |
| Yang et al. | China | 2007 | 1996–2003 | Case crossover | HAs | All | ICD-9 | No |
| Schouten et al. | Netherlands | 1996 | 1977–1989 | Time series | EDVs | All | ICD-9 | Adjust |
| Strosnider et al. | USA | 2018 | 2000–2014 | Time series | EDVs | ≥19 years | ICD-9 | No |
| Anderson et al. | Europe | 1997 | 1977–1992 | Time series | EDVs | All | ICD-9 | Adjust |
| Stieb et al. | Canada | 2009 | 1992–2003 | Time series | EDVs | All | ICD-9/ICD-10 | No |
| Medina-Ramon et al. | USA | 2006 | 1986–1999 | Case crossover | HAs | ≥65 years | ICD-9 | No |
Note: EDVs, emergency department visits; HAs, hospital admission visits.
Figure 2Forest plot of short-term ambient level ozone exposure and COPD hospitalizations. Excess risk (ER) of COPD hospitalizations per 10 µg/m3 increase in maximum 8-h ozone concentration.
Figure 3Subgroup analyses among different age ranges, seasons and co-pollutants. Note: ER, excess risk.
Figure 4Subgroup analyses among different lag structures. Note: ER, excess risk.